IMMUNE RESISTANCE VIA A PD-1/PD-L1 MECHANISM IN GLIOBLASTOMA
Immunotherapy is a treatment option that is becoming more common for different types of cancer. The idea behind this therapy is to modify the patient's immune system. One type of this therapy involves blocking the binding between PD-1 and PD-L1. By doing so, it enables increased antitumor immun...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Avicenna Tajik State Medical University
2023-12-01
|
| Series: | Паёми Сино |
| Subjects: | |
| Online Access: | https://doi.org/10.25005/2074-0581-2023-25-4-509-519 |